KeynoteAdvances in the development of entry inhibitors for sialic-acid-targeting viruses
Cited by (0)
Rick Heida received his master’s degree in biomedical sciences at the University of Groningen in the Netherlands in 2017, with a main interest in microbiology and immunology. Currently, he is pursuing his PhD at the department of Pharmaceutical Technology and Biopharmacy at the University of Groningen under the supervision of Henderik W. Frijlink, Anke L.W. Huckriede and Wouter L.J. Hinrichs. His research focuses mainly on the evaluation of antiviral entry inhibitors with broad-spectrum potential and their suitability to be formulated as dry-powder formulations. In line with this, he works on optimizing methods for pulmonary administration of dry-powder formulations in small laboratory animals.
Yoshita C. Bhide completed her PhD in virology and immunology in 2018 at the University of Groningen under the supervision of Anke L.W. Huckriede. Her PhD research focused on improved and cross-protective influenza vaccine evaluation in vivo. She is now working as a postdoctoral researcher with Henderik W. Frijlink. Her current research focuses on in vitro and in vivo evaluation of novel entry inhibitors against influenza viruses. Her research has resulted in several peer-reviewed publications. Being a trained virologist, her research interests are in infectious diseases, especially viral pathogenesis and immune modulation, and the development of vaccines and antivirals.
Matteo Gasbarri received his master’s degree in materials science at the Tor Vergata University of Rome. His master thesis focused on flexible perovskite solar cells and was carried out at the Center for Hybrid and Organic Solar Energy (CHOSE). In 2017, he joined Saule Technologies, developing new generation perovskite photovoltaic cells. Since September 2017, he has been a PhD student in the Supramolecular Nanomaterials and Interfaces Laboratory (SuNMIL) at École Polytechnique Fédérale de Lausanne (EPFL), under the supervision of Francesco Stellacci. His research is primarily focused on the development and physicochemical understanding of non-toxic broad-spectrum antiviral nanomaterials.
- ⁎⁎
These authors contributed equally.